SHARE

Stada considers €6bn acquisition of CVC-backed Cooper Consumer Health

The German pharmaceuticals group is considering the potential acquisition to support expansion in consumer health markets. Cooper is majority-owned by CVC Capital Partners and the deal would follow Stada’s strong recent performance.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.